Product Description

Product Profile: AC-262536 AC-262536 is a selective androgen receptor modulator (SARM) distinguished by its exceptionally mild profile and high safety margins. It was developed to provide anabolic support—specifically muscle growth and strength maintenance—without inducing the adverse androgenic effects on non-target organs (such as the prostate) typically associated with traditional anabolic agents. It is widely regarded as one of the most gentle compounds in the SARM class, making it ideal for research involving muscle preservation during caloric deficits, aging, or reduced physical activity.

Mechanism of Action AC-262536 functions by selectively binding to androgen receptors to trigger anabolic processes in skeletal muscle. Pharmacologically, it exhibits approximately 60% of the anabolic potency of testosterone but with a significantly reduced androgenic load. Notably, the compound does not aromatize into estrogen, eliminating risks associated with water retention and gynecomastia, resulting in a “dry” and stable improvement in body composition.

Comparative Analysis

• vs. Ostarine (MK-2866): While sharing a similar safety profile, AC-262536 is generally considered to have a weaker anabolic drive than Ostarine. It is best utilized for restorative models or long-term maintenance where minimal physiological stress is required.

• vs. ACP-105: AC-262536 is the milder of the two. While ACP-105 offers more noticeable muscle stimulation, AC-262536 is superior for users seeking the absolute minimum impact on the hormonal axis.

• vs. Ligandrol (LGD-4033): Ligandrol is a potent mass builder with higher suppression risks. AC-262536 serves as a gentle alternative, offering controlled stimulation without aggressive growth or significant hormonal disruption. It is effectively paired with non-hormonal compounds like Ibutamoren.

Administration Protocol

• Standard Dosage: 5 units once daily.

• Cycle Duration: 4–6 weeks, followed by a 2–4 week recovery period.

• Concentration: 1 unit is equivalent to 23.33mcg.

• Capacity: Each pen contains 150 units.

Safety Profile AC-262536 is characterized by excellent tolerability. However, dose-dependent, temporary suppression of endogenous testosterone may occur. Long-term safety data is currently limited, necessitating strict adherence to cycle guidelines.